Farminveste - SGPS SA Class B

Farminveste - SGPS SA Class B

EEURONEXT:MLFMV
5.00
EUR
0.00
(0.00%)
50.00MMarket Cap
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
72.79
35.03
35.14
35.25
38.29
38.33
39.96
41.56
41.38
42.23
- -
- -
Basic EPS, GAAP
- -
- -
0.57
0.15
0.11
-0.76
0.1
0.18
0.52
0.56
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
0.24
0.49
0.21
0.25
0.33
0.22
- -
- -
Book Value per Share
- -
- -
11.77
12.36
5.9
5.23
5.4
6.08
6.93
7.5
- -
9.85
Tangible Book Value per Share
- -
- -
-5.87
-6.67
-3.77
-4.57
-4.75
-3.89
-2.63
-1.19
- -
1.06
Basic Weighted Avg Shares
10
20
20
20
20
20
20
20
20
20
20
20
Sales/Revenue/Turnover
691
701
703
705
766
767
799
831
828
845
- -
- -
Operating Margin (%)
5.28
4.18
2.97
1.59
2.84
0.48
1.86
1.84
1.86
1.75
- -
- -
Depreciation Expense
- -
- -
7
9
15
15
15
17
14
14
- -
- -
Net Income, GAAP
- -
- -
11
3
2
-15
2
4
10
11
- -
- -
Effective Tax Rate (%)
- -
- -
18.56
24.78
28.62
- -
51.84
31.04
14.9
19.43
- -
- -
Profit Margin (%)
- -
- -
1.63
0.43
0.28
-1.98
0.24
0.44
1.25
1.32
- -
- -
Working Capital
-6
-27
-1
-13
-74
-72
-44
-35
-32
36
- -
-2
LT Debt
- -
- -
132
133
119
127
148
150
143
127
- -
126
Total Equity
- -
- -
169
176
178
160
168
183
204
207
- -
278
Return on Invested Capital (%)
- -
- -
- -
3.86
4.34
- -
3.03
4.37
5.84
5.85
- -
- -
Return on Capital (%)
- -
- -
- -
0.47
0.43
- -
-0.35
0.5
3.09
3.43
- -
- -
Return on Common Equity (%)
- -
- -
- -
2.66
1.81
-13.62
1.8
3.18
7.93
7.74
- -
- -

Capital Structure

EUR

•

in mil. unless spec.
Jun'24
Dec'24
Jun'25
ST Debt
110
122
89
LT Borrowings
133
118
118
LT Finance Leases
12
9
8
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
20
20
20
Market Capitalization
24
24
50

Working Capital

EUR

•

in mil. unless spec.
Jun'24
Dec'24
Jun'25
Total Current Assets
262
282
221
Cash, Cash Equivalents & STI
52
103
31
Accounts Receivable, Net
100
76
76
Inventories
73
69
76
Total Current Liabilities
278
246
224
Payables & Accruals
- -
- -
- -
ST Debt
110
122
89
Deferred Revenue
- -
- -
- -

Growth Rates

EUR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
- -
Free Cash Flow
- -
- -
- -
Net Income, GAAP
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
828
2024
- -
- -
845
2025
- -
- -
- -

Semi-annual Earnings Per Share

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
0.52
2024
- -
- -
0.56
2025
- -
- -
- -

Semi-annual Dividends Per Share

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
0.33
2024
- -
- -
0.22
2025
- -
- -
- -

Company Description

CEO
Maria da Luz Toregão Romão Sequeira
Full Time Employees
1,685
Sector
Finance
Industry
Financial conglomerates
Address
Travessa de Santa Catarina nº. 8 Lisbon LI Portugal 1200-403
IPO Date
Oct 16, 2018
Business
Farminveste, S.G.P.S., S.A. functions as a diversified holding entity, with its operations spanning across crucial segments of the healthcare sector through its various subsidiaries. The company is actively involved in the distribution of pharmaceutical products within Portugal, holding a significant indirect stake in Alliance Healthcare. Additionally, it provides direct healthcare services, evidenced by its indirect participation in CUF, S.A., which oversees a network of over ten hospitals and several clinics across numerous locations in Portugal, including Lisbon, Porto, and Coimbra. The group extends its influence into information technologies for the healthcare industry through its majority indirect ownership of Glintt Global, a Portuguese multinational specializing in digital health ecosystems. Farminveste also leads in health market intelligence, conducting research and studies in Portugal, Spain, and Ireland through its wholly-owned HMR Health Market Research International subsidiary. Further expanding its reach, the company engages in the management and enhancement of pharmacy operations, notably through its "Farmácias Portuguesas" brand, and strategically invests in the real estate sector, primarily supporting its integrated healthcare activities. Established in 2010 and headquartered in Lisbon, Portugal, Farminveste, S.G.P.S., S.A. serves as a key corporate arm of the Associacao Nacional das Farmacias.